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INTRODUCTION
The association of anti-idiotypic (Id)' anitibo(lies with certain immunoregulatory phenomenia has been clearly demonstrated in animal models. For example, idliotypespecific suppression of the growth of mouse myelomiia cells can be demonstrated in mice with anti-Id antibodies (1) (2) (3) (4) . Furthermore, anti-Id antibodies are able to suppress the synthesis by normal B cells of antibodlies carrying the relevant idiotypes. This suppression can be the result of either a direct effect of anti-Id antibodies on the precursors of antibody-forming cells, as shown in the inulin and phosphorylcholine systems (5, 6) , or by generation of suppressor T cells that can inhibit helper functions in the arsonate and streptococcal systems (7, 8) .
In the present paper, we report studies of a patient with chronic lymphocytic leukemia (CLL) who had high titer serumi monoclonial immilunoglobulin (Ig)M antisheep erythrocyte (SRBC) antibody, and whose B cells expressed surface IgM with anti-SRBC specificity. An anti-Id antibody was produced by immunizing sheep with the monoclonal serum anti-SRBC antibody, followed by multiple absorptions against pooled normal serum IgM. The anti-SRBC anitibody in the serum and on the surface of the patient's B cells was shown to be idiotypically identical. Furthermiore, the aniti-Id antibody suppressed the spontanieous secretion of anti-SRBC antibody by the leukemic B cells as well as the pokeweed mitogen (PWM)-induced ainti-SRBC antibody production as measured by a hemolysis-inigel plaque-formiinig cell (PFC) assay.
METHODS
Patienit. The patient is a 64-yr-old miale who was liagniosed as having CLL. The diagniosis of CLL is based on a total leukocyte counit ranginig from 7,000 to 20,000 cells/mm11113 with a range of 40-90% lymphocytes. Up to 80% of the lymphocytes bear surface Ig (IgM, K-light chaini). The patienit has never received therapy for his CLL.
Cell suspensioms. Heparinize ofanti-SRBC PFC after polyclonal stimulation ofhuman blood lymphocytes with PWM were carried out according to methodologies that have been previously described in detail (10, 11) .
Assay for PFC. Lymphocytes were assayed for direct PFC against SRBC by an ultrathin layer complemenit dependent hemolysis-in-gel technique as previously described in detail (10, 11) . This was performed on cells obtained immediately after separation from blood (spontaneous PFC) and after 7 d in culture with or without PWM.
Preparation of anti-Id antisera. Three strain 13 guinea pigs were immunized with 100 ,tg of the patient's monoclonal IgM anti-SRBC antibody emulsified in Freund's complete adjuvant. Starting 4 wk after immunization, the guinea pigs were bled weekly and sera were screened in an immunodiffusion assay for antibodies to IgM. Sheep 3501 (National Institutes of Health Animal Farm, Poolesville, Md.) was immunized with 3 ml of packed autologous SRBC (3501-SRBC) coated with 100 ,ug of the patient's monoclonal IgM anti-SRBC antibody emulsified in Freund's complete adjuvant. Adsorption of the antibody was performed by incubation of 3501-SRBC with the monoclonal IgM for 1 h at room temperature. After immunization, the sheep were bled weekly and precipitating antibodies were dletected by immunodiffusion. Guinea pig and sheep anti-Id sera were made specific for the patient's monoclonal IgM by five adsorptions, on an immunoadsorbent prepared according to Avremeas et al. (12) , from a pool of normal IgM as well as from a Waldenstrom's macroglobulin (kindly provided by Dr. Henry Metzger, National Institutes of Health, Bethesda, Md.).
Determination of anti-Id activity of guinea pig and sheep antisera. After five adsorptions of an immunoadsorbent prepared from normal IgM or a macroglobulin, determination of anti-Id activity was performed by two methods: (a) A hemagglutination assay in microtiter plates using horse erythrocytes coated by the chromic chloride method (13) with the patient's monoclonal IgM, the patient's IgG, and IgM from normal healthy subjects. The titers were expressed as 1/log2 of the highest dilution of antisera giving agglutinationi. (b) A radioimmunoassay in microtiter plates using sheep or guinea pig anti-Id antibodies and l25I-labeled patient's monoclonal IgM.
In addition, a hemagglutination inhibition assay was used to test the ability of anti-Id antibodies to react with the combining site ofmonoclonal IgM as described previously (13) .
Effect of anti-Id antisera on anti-SRBC PFC. To determine the effect of anti-Id antibody on spontaneous anti-SRBC PFC, freshly drawn lymphocytes from the patient and from three normal individuals were immediately placed in the PFC assay with agar into which various dilutions of the sheep and guinea pig pre-and postinmuinization antisera were added. After 2 h of incubation guinea pig complement was added and incubation was continued for an additional hour. PFC were then counted using a dissecting microscope.
To determine the effect of anti-Id antibody on PWMinduced PFC, various dilutions of the above antisera were added on day 0 directly to lymphocyte cultures from the patient and three normal individuals in the presence and absence of PWM. PFC were counted after 6 d of culture. In separate experiments, to control for the carry-over of anti-Id antibody from the cultures to the assay system, cultures were done for 6 (14) to determine whether the anti-Il blocked the expression of surface Ig.
To determine whether the idiotypic determiniants were present on T cells, TCE suspensions were obtained from two normal individuals by the E-rosette enrichment method (9) and by the nylon wool column method, and from the patient by the nylon wool method. The E-rosette enrichment method was inadequate in obtaining purified TCE suspensions fromil the patient, because the patient's B cells expressed surface Ig with anti-SRBC activity and consequently bound to the SRBC to form E rosettes (15) .
The sheep control and anti-Id antisera were conjugated with fluorescein isothiocyanate, and the TCE suspensions of the patient and normals were assayed for the presence of i(liotypic determinants.
To determine whether anti-Id determinants were present oni T cells, nylon-purified TCE suspensions fronm the patient and two normal individuals were preincubated for 30 min at 37°C with a 1:10 dilution of the patient's IgM, IgG, and a normal IgM. Cells were washed and binding of the different Ig was determinedl by reacting the cells with fluoresceinated goat anti-human Ig.
RESULTS
Fractiotnation of seortuml oni Sephadex G-200 colinimns.
Normal serum pooled from four donors, as well as serum from the patient, were fractionated separately on Sephadex G-200 columns (Pharmacia Diagniostics, Div. of Pharmacia Inc., Piscataway, N. J.). SRBC hemagglutinins were tested on fractions that included both IgM and IgG. Anti-SRBC hemagglutination activity was found predominaintly in the IgM fractions of the patient. These fractions were pooled and used to raise anti-Id sera.
Determination of an ti-Id activity of guinlea pig an(1 sheep antisera. Data in Table I demonstrate that both guinea pig and sheep antisera contain anti-IgM antibodies but that after five adsorptions on pooled normal human IgM only anti-Id antibodies were detected. These five-times-adsorbed sera were subsequently used in the radioimmunoassay. A dose-effect relationship between the dilution of these antisera and the binding of 1251-labeled IgM (patient) was observed indicating that both guinea pig and sheep antisera contain anti-Id antibodies (Fig. 1) .
Specificity ofanti-Id antisera. The ability of guinea pig and sheep anti-Id antisera to react with the combining site of the patient's IgM anti-SRBC antibodies was studied in a hemagglutination inhibition assay. The data presen-ted in Fig. 2 and Table II show that only sheep anti-Id antibody was able to inhibit the hemagglutinationi activity of the patient's IgM aniti-SRBC antibodies. These data suggest that anti-Id antibodies produced in sheep were comnbiniing site specific, whereas guinea pig antibodies were directed against some other antigenic determinant, probably located on the framework of the variable region of the IgM anti-SRBC antibody, but apparently not related to the combining site. Effect of antti-Id antisera otn sponitanieous anlti-SRBC PFC. The effect of various dilutions of the anti-Id antisera on the spontaneous anti-SRBC PFC from the patient is shown in Fig. 3 . Neither sheep nor guinea pig preimmunization sera inhibited spontaneous anti-SRBC PFC at any dilution tested. However, the sheep anti-Id that is most likely specific for the anti-SRBC combining site completely suppressed PFC responses at dilutions of 1:100 and 1:300, and suppressed to almost 50% ofcontrol at a dilution of 1:1,000. On the other hand, the guinea pig anti-Id, which, as shown in Fig. 2 and Table II, is likely specific for determinants other than the combining site of the idiotypic antibody, failed to suppress PFC responses.
Because normal individuals do not express spontaneous anti-SRBC PFC before culture with PWM, it was impossible to determine the effect ofthe various anti-Id antisera on unstimulated normal lymphocytes.
Effect of anti-Id antisera on1 PWVM-inidtuced anti-SRBC PFC. The effects of various dilutions of anti-Id antisera on the PWM-induced anti-SRBC PFC of a normal individual and the patient are shown in Figs. 4 and 5, respectively. Neither preimmunization nor anti-Id antisera from sheep or guinea pig suppressed the PWM-induced PFC of the normal individual (Fig.  4) . This experiment was done three times using three different normnal subjects and the results were similar in each, i.e., no suppression. With the patient there was no suppression with either sheep or guinea pig preimmnunization sera. However, sheep anti-Id antiserumn, which blocks the combining site of the patient's monoclonal IgM anti-SRBC antibody, markedly sup- 1:100 FIGURE 1 Binding of various antisera to '25I-labeled patient IgM. Neither sheep nor guinea pig preimmunization antisera bound to the patient's IgM. However, both sheep and guinea pig postimmunization antisera, after multiple adsorptions with pooled normal IgM and a macroglobulin from a patient with Waldenstrom's macroglobulinemia, did not bind to normal IgM (Table I) . Hence, both sheep and guinea pig postimmnunization antisera were directed against the patient's IgM idiotype. *, sheep preimmunization; 0, sheep anti-Id; A, guinea pig preimmllunization; A, guinea pig anti-Id.
pressed the PWM-induced anti-SRBC PFC at a dilution of 1:30. In addition, there was a lesser degree of, but nonetheless obvious suppression at higher dilutions (Fig. 5) . On the other hand, the guinea pig anti-Id antiserum, which reacts with noncombining site determinants, did not suppress. It was highly unlikely that the suppression seen in the PWM-stimulated cultures, which contained sheep (22) . This is somilewhat at variance with previouis reports of alhelper T-cell defect in CLL (23) . However, the latter stuidies were not employiing the PWMI-induiced anti-SRBC PFC systemi.
In the present stuidy, using ptirified serum monoclonal IgMI with anti-SRBC specificity, we succeeded in raisinig aniti-Id antibody. VH and VL genes ofthe CLL B cells. However, there are other alternatives that have not been completely ruled out. For example, the anti-Id antibody may have been directly cytotoxic to the CLL cells. This is unlikely, however, because the viability of the cells was not altered by the anti-Id antibody. Alternatively, the antiId antibody could have been bound to and blocked the anti-SRBC antibody in the agar after it had been secreted. This might explain the effect of the anti-Id antibody in the experiments in which the antibody was added directly to the assay system in the detection of spontaneously secreting anti-SRBC antibody on day 0. However, it is highly unlikely in cultures stimulated with PWM and subsequently washed three times that enough anti-Id antibody could have been carried over into the assay system to interfere with the binding of antibody and thus explain the suppression by that mechanism. To directly control for this possibility, experiments were carried out in which the patient's lymphocytes were cultured for 6 d with PWM in the absence of the sheep anti-Id antibody. At the termination of culture, a 1:30 dilution of the anti-Id was added to culture immediately before harvesting and plaquing. The cultures were then washed three times and the cells plated for plaquing. Under these circumstances, there was no inhibition of the PFC response. Thus, although it is still conceivable that there could have been carry-over anti-Id from the original PWM-stimulated cultures that contained anti-Id into the assay system, the latter control experiment makes this highly unlikely. It is also unlikely that the anti-Id blocked the PWM receptor on the CLL lymphocyte because even the spontaneous secretion of anti-SRBC antibody was blocked by the anti-Id.
The suppression was not overcome by a powerful stimulus such as a polyclonal B-cell activator, in this case, PWM. This is of interest in that other data have indicated that tolerance induced by antigen or antibody (allotypic suppression) could be broken by polyclonal B-cell activators (24, 25) . It should be pointed out, given the report of idiotypic determinants on T cells (26) 
